Optimization of Multistage Testing Times and Critical Values in Clinical Trials
From MaRDI portal
Publication:4274356
DOI10.2307/2532197zbMath0800.62696OpenAlexW2331062220WikidataQ72610218 ScholiaQ72610218MaRDI QIDQ4274356
Kent R. Bailey, Erica H. Brittain
Publication date: 6 January 1994
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2532197
Related Items (4)
The Influence of Biostatistics at the National Heart, Lung, and Blood Institute ⋮ Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches ⋮ Basic concepts of group sequential and adaptive group sequential test procedures ⋮ THE ATTRACTIVENESS OF THE CONCEPT OF A PROSPECTIVELY DESIGNED TWO-STAGE CLINICAL TRIAL
This page was built for publication: Optimization of Multistage Testing Times and Critical Values in Clinical Trials